Scientific Online Resource System

Scripta Scientifica Medica

Hyperbaric oxygen therapy for severe ulcerative colitis refractory to conventional therapies. Case report

Ivaylo Vazharov

Abstract

Ulcerative colitis (UC) is a disease of unknown etiology characterized by inflammation of the mucosa and occasionally the submucosa of the colon. Conventional drug therapy for UC involves use of aminosalicylates (oral, topical, or both) for mild to moderate disease, corticosteroids, azathioprine/6-mercaptopurine, cyclosporine and anti-tumor necrosis factor therapy for a more severe disease. Those patients who do not respond to that therapy may require colectomy. In this article the successful use of hyperbaric oxygen therapy in the treatment of ulcerative colitis refractory to conventional therapies is described.


Keywords

Hyperbaric oxygen therapy, Ulcerative colitis.

Full Text


References

Dulai PS, Gleeson MW, Taylor D, Holubar SD, Buckey JC, Siegel CA. Systematic review: The safety and efficacy of hyperbaric oxygen therapy for inflammatory bowel disease. Aliment Pharmacol Ther. 2014 Jun;39(11):1266-75.

Rossignol DA. Hyperbaric oxygen treatment for inflammatory bowel disease: a systematic review and analysis. Med Gas Res. 2012 Mar 15;2(1):6.

Thom SR. Hyperbaric oxygen: its mechanisms and efficacy. Plast Reconstr Surg. 2011 Jan;127 Suppl 1:131S-141S.

Rachmilewitz D, Karmeli F, Okon E, Rubenstein I, Better OS. Hyperbaric oxygen: a novel modality to ameliorate experimental colitis. Gut 1998;43:512-9.

Truelove SC, Witts LJ. Cortisone and corticotrophin in ulcerative colitis. Br Med J. 1959 Feb 14;1(5119):387-94.

Schroeder KW, Tremaine WJ, Ilstrup DM. Coated oral 5-aminosalicylic acid therapy for mildly to moderately active ulcerative colitis. A randomized study. N Engl J Med. 1987;317:1625-29.

Satsangi J, Silverberg MS, Vermeire S, Colombel JF. The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications. - Gut, 55, 2006, No. 6, 749-753.

Gill AL, Bell CN. Hyperbaric oxygen: its uses, mechanisms of action and outcomes. QJM. 2004;97(7):385-395.

Saito K, Tanaka Y, Ota T, Eto S, Yamashita U. Suppressive effect of hyperbaric oxygenation on immune responses of normal and autoimmune mice. Clin Exp Immunol. 1991 Nov;86(2):322-7.

Al-Waili NS, Butler GJ. Effects of hyperbaric oxygen on inflammatory response to wound and trauma: possible mechanism of action. ScientificWorld- Journal. 2006;6:425-441.




DOI: http://dx.doi.org/10.14748/ssm.v49i1.1913
About The Author

Ivaylo Vazharov
Military Medical Academy
Bulgaria

Clinic of Internal Diseases, Naval Hospital-Varna

Font Size


|